The impact of screening for asymptomatic myocardial ischemia in individuals with type 2 diabetes

Journal of Cardiovascular Nursing

Volumn 21, Issue 2, 2006, Pages E1-E7

  Chyun, Deborah A ^a   Katten, Deborah M ^b   Melkus, Gail D ^a   Talley, Sandra ^c   Davey, Janice A ^c   Wackers, Frans J Th ^c  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

^b HARTFORD HOSPITAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Coronary artery disease; Depression; Diabetes mellitus; Quality of life; Screening

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; FIBRINOLYTIC AGENT;

AGE; AGED; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; EMOTION; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSONAL AUTONOMY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SOCIOECONOMICS; STATISTICS;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; ANXIETY; ASPIRIN; DEPRESSION; DIABETES MELLITUS, TYPE 2; EMOTIONS; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PERSONAL AUTONOMY; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK ASSESSMENT; SOCIOECONOMIC FACTORS;

EID: 33745609808     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/00005082-200603000-00015     Document Type: Article

References (42)

1. Fox S, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA. 2004;292:2495-2499.
2. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. N Engl J Med. 1984;311:1144-1147.
3. Wackers FJT, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD Study. Diabetes Care. 2004;27:1954-1961.
4. Valensi P, Sachs R-N, Harfouche B, et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care. 2001;24:339-343.
5. Glanz K, Brekke M, Hoffman E, et al. Patient reactions to nutritional education for cholesterol reduction. Am J Prev Med. 1990;6:311-317.
6. Allen S, Bache-Wiig M, Hunninghake D. Patient perceptions about the influence of cholesterol on heart disease. Am J Prev Med. 1992;8:30-36.
7. Fischer P, Guinan K, Burke J, et al. Impact of a public cholesterol screening program. Arch Intern Med. 1990;150:2567-2572.
8. Tymstra TJ, Bieleman B. The psychological impact of mass screening for cardiovascular risk factors. Fam Pract. 1987;4:287-290.
9. Shaw C, Abrams K, Marteau TM. Psychological impact of predicting individual's risks of illness: a systematic review. Soc Sci Med. 1999;49:1571-1598.
10. Hyman D, Flora J, Reynolds K, et al. The impact of public cholesterol screening on diet, general well-being, and physician referral. Am J Prev Med. 1991;7:268-272.
11. Fitzgerald S, Gibbens S, Agnew J. Evaluation of referral completion after a workplace screening program. Am J Prev Med. 1991;7:335-340.
12. Owen N, James R, Henrikson D, et al. Community cholesterol screenings: the impact of follow-up letters and incentives on retest rates and biometric changes in follow-up screenings. Am J Health Promot. 1990;5:58-62.
13. Kash KM, Holland JC, Halper MS, et al. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst. 1992;84:245-256.
14. Lerman C, Daly M, Sands C, et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Am Cancer Inst. 1993;85:1074-1080.
15. Freedman DS, Byers T, Barrett DH, et al. Plasma lipid levels and psychologic characteristics in men. Am J Epidemiol. 1995;141:507-517.
16. Lane JD, McCaskill CC, Williams PG, et al. Personality correlates of glycemic control in type 2 diabetes. Diabetes Care. 2000;23:1321-1325.
17. Frank E, Rothenberg R, Lewis C, et al. Correlates of physicians' prevention-related practices. Findings from the Women Physicians' Health Study. Arch Fam Med. 2000;9:359-367.
18. Lagerlund M, Sparen P, Thurfjell E, et al. Predictors of non-attendance in a population-based mammography screening programme: socio-demographic factors and aspects of health behaviour. Eur J Cancer Prev. 2000;9:25-33.
19. Pho K, Geller A, Schroy PC. Lack of communication about familial colorectal cancer risk associated with colorectal adenomas. Cancer Causes Control. 2000;11:543-546.
20. Deci EL, Ryan RM. The "what" and "why" of goal pursuits: human needs and the self-determination of behavior. Psychol Inq. 2000;11:227-268.
21. Williams G, Freedman Z, Deci EL. Supporting autonomy to motivate patients with diabetes for glucose control. Diabetes Care. 1998;21:1644-1651.
22. Ryan RM, Deci EL. On happiness and human potentials: a review of research on hedonic and eudaimonic well-being. Annu Rev Psychol. 2001;52:141-166.
23. Williams GC, Rodin GC, Ryan RM, et al. Autonomous regulation: the motivational basis of adherence to medical regimens. Health Psychol. 1998;17:169-176.
24. Crown S, Crisp AH. A short clinical diagnostic self-rating scale for psychoneurotic patients. The Middlesex Hospital questionnaire. Br J Psychiatry. 1966;112:917-923.
25. Kawachi I, Colditz GA, Ascherio A, et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation. 1994;891:992-1997.
26. Crisp AH, Queenan M, D'Souza MF. Myocardial infarction and the emotional climate. Lancet. 1984;1:616-619.
27. Roberts RE, Vernon SW. The Center for Epidemiologic Studies Depression Scale: its use in a community sample. Am J Psychiatry. 1983;140:41-46.
28. Cole S, Kawachi I, Maller S, et al. Test of item-response bias in the CES-D scale: experience from the New Haven EPESE study. J Clin Epidemiol. 2000;53:285-289.
29. Radloff LS. The CES-D Scale: a self-report depression scale for researching the general population. Appl Psychol Meas. 1977;1:385-401.
30. Ware J, Sherbourne C. The MOS 36-item short-form health survey (SF-36): conceptual framework and item selection. Med Care. 1992;30:473-481.
31. Ware JE. SF-36 Health Survey: Manual and Interpretation Guide. Boston, Mass: The Health Institute, New England Medical Center; 1993.
32. Williams GC, Deci EL. The National Cancer Center Institute Guidelines for Smoking Cessation: do they motivate quitting? J Gen Intern Med. 1996;11:138.
33. SAS. Statistical Analysis Software. Cary, NC; SAS Institute; 2003.
34. Lustman PJ, de Groot M, Anderson RJ, et al. Depression and poor glycemic control. Diabetes Care. 2000;23:934-942.
35. Rumsfeld JS, MaWhinney S, McCarthy M, et al. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. JAMA. 1999;281:1298-1303.
36. Sullivan MD, LaCroix AZ, Spertus JA, et al. Five-year prospective study of the effects of anxiety and depression in patients with coronary artery disease. Am J Cardiol. 2000;86:1135-1138.
37. Helgeson VS, Heidi F. Cognitive adaptation as a predictor of new coronary events after percutaneous transluminal coronary angioplasty. Psychosom Med. 1999;61:488-495.
38. van Elderen T, Maes S, Dusseldorp E. Coping with coronary heart disease: a longitudinal study. J Psychosom Res. 1999;47:175-183.
39. Pratt LA, Ford DE, Crum RM, et al. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation. 1996;94:3123-3129.
40. Rose MR, Schirop T, Fliege H, et al. The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control. Diabetes Care. 2002;25:35-42.
41. Pooley CG, Gerrard C, Hollis S, et al. "Oh it's a wonderful practice. you can talk to them"; a qualitative study of patients' and health professionals' views on the management of type 2 diabetes. Health Soc Care Community. 2001:9-11.
42. Saydah S, Fradkin J, Cowie C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;29:335-342.